Surgical Devices · Newark, DE · Founded 2012 · Privately Held (backing)
Developer of medical devices designed to treat pelvic organ prolapse disease in women. FEMSelect is based in Newark, DE and was founded in 2012. It was valued at $17 million at its later-stage round in Sep 2022, the last priced event on record. It has raised $12.2 million across 1 recorded round; the latest was an accelerator round in Jan 2018.
PMV mark · valuation
$17.0M
Oct 2026
Priced at
its later-stage round
Sep 2022
Total raised
$12.2M
Last round
Accelerator/Incubator
Jan 2018
Team — not yet on record
No current team members for FEMSelect are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of FEMSelect with a free account
·The complete investor list: 21 names
·Watch FEMSelect: the Monday email on marks, rounds and moves
